India's Strides Pharma halts U.S. sales of heartburn drug

India's Strides Pharma Science Ltd said on Friday it has halted sales of its heartburn drug Ranitidine in the U.S. market as it conducts tests to identify possible cancer-causing impurities in the tablets.

from Reuters: Health News https://ift.tt/2meIpcH
via IFTTT